| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 06/20/2001 | EP1107731A1 Synthetic tear fluid |
| 06/20/2001 | EP1107729A1 Electrically controlled transport of charged penetrants across barriers |
| 06/20/2001 | EP0863933B1 Novel hydrogels containing triblock copolymers, and preparation and use thereof |
| 06/20/2001 | EP0817621B1 Pharmaceutical composition for transdermic delivery |
| 06/20/2001 | EP0618962B1 Thymidine phosphorylase for use in the modulation of cellular proliferation or chemotaxis |
| 06/20/2001 | CN1300295A Hybrid protein for inhibiting the deatanulation of mastocytes and the use thereof |
| 06/20/2001 | CN1300280A Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol |
| 06/20/2001 | CN1300216A Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts of hydrates |
| 06/20/2001 | CN1300213A Gamma-contained aminobutyric acid derivatives solid compositions and preparation process thereof |
| 06/20/2001 | CN1300208A Icecream-type pharmaceutical formulation and process for preparing the same |
| 06/20/2001 | CN1299683A Solvent diluent for painless penicillin |
| 06/20/2001 | CN1067410C Improved preparation method for biodegradable polymeric microspheres using solvent extraction and preparation method for microspheres for treating local inflammation using same |
| 06/20/2001 | CN1067277C Chewing medicinal piece of qi ju dihuang wan and prepe method thereof |
| 06/20/2001 | CN1067240C Medicinal plaster stroma |
| 06/19/2001 | US6248870 Unsymmetrical complexing agents and targeting immunoreagents useful in therapeutic and diagnostic compositions and methods |
| 06/19/2001 | US6248780 Therapy for breast cancer |
| 06/19/2001 | US6248779 Synergistic mixture of vitamin e and squalane |
| 06/19/2001 | US6248771 Formulations for hydrophobic pharmaceutical agents |
| 06/19/2001 | US6248763 Psoriasis |
| 06/19/2001 | US6248758 Pharmaceutical antacid |
| 06/19/2001 | US6248734 Use of photodynamic therapy for prevention of secondary cataracts |
| 06/19/2001 | US6248731 Stabilized aspirin compositions and method of preparation for oral & topical use |
| 06/19/2001 | US6248391 Mixing primary film-former comprising dextrose, auxiliary film-former, sodium citrate and titanium dioxide into water to form aqueous coating dispersion, applying dispersion onto substrates, drying white film coating |
| 06/19/2001 | US6248390 Fiber-water—water containing soluble fiber |
| 06/19/2001 | US6248375 Food bar |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248361 Water-soluble folic acid compositions |
| 06/19/2001 | US6248360 Complexes to improve oral absorption of poorly absorbable antibiotics |
| 06/19/2001 | US6248358 Bioadhesive progressive hydration tablets and methods of making and using the same |
| 06/19/2001 | US6248355 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation |
| 06/19/2001 | US6248350 Antiinflammatory analgesic patch |
| 06/19/2001 | US6248348 Incorporating poly-N-vinly amide in a transdermal system |
| 06/19/2001 | US6248345 Prolonged anesthesia in joints and body spaces |
| 06/19/2001 | US6248343 Mixture of triclosan and plant extract |
| 06/19/2001 | US6248335 Ph control |
| 06/19/2001 | US6248334 Process for preparing conjugate vaccines including free protein and the conjugate vaccines, immunogens, and immunogenic reagents produced by this process |
| 06/19/2001 | US6248332 Targeted immunostimulation with bispecific reagents |
| 06/19/2001 | US6248327 Using antibody |
| 06/19/2001 | US6248057 Absorbable brachytherapy and chemotherapy delivery devices and methods |
| 06/19/2001 | CA2219050C Polyamine derivatives as radioprotective agents |
| 06/19/2001 | CA2172187C Method of incorporating drugs into a polymer component of stents |
| 06/19/2001 | CA2038577C Utilization and delivery of enzymes |
| 06/19/2001 | CA1341259C Particle vector useful as a carrier of biologically active molecules, and a fabrication method |
| 06/14/2001 | WO2001042586A1 A ventilating device for ventilating through a ridge |
| 06/14/2001 | WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 06/14/2001 | WO2001042411A1 Compositions including ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | WO2001042390A1 Stabilizer for unsaturated compounds or stuff containing the compounds and method of stabilization |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | WO2001042231A2 Polyhydroxystilbenes and stilbene oxides as antisoriatic agents and protein kinase inhibitors |
| 06/14/2001 | WO2001042221A1 Solid-state form of celecoxib having enhanced bioavailability |
| 06/14/2001 | WO2001042200A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules |
| 06/14/2001 | WO2001041912A2 Ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | WO2001041911A2 Process for preparing ether-capped poly(oxyalkylated) alcohol surfactants |
| 06/14/2001 | WO2001041909A1 Compositions including ether-capped poly(oxyalkylated) alcohol wetting agents |
| 06/14/2001 | WO2001041823A2 Radioactive compositions and methods of use thereof |
| 06/14/2001 | WO2001041822A1 Mineral-polymer hybrid composition |
| 06/14/2001 | WO2001041821A1 Mineral-polymer hybrid composition |
| 06/14/2001 | WO2001041813A2 Methods of treating lupus based on antibody affinity and screening methods and compositions for use thereof |
| 06/14/2001 | WO2001041812A2 Amphiphilic polymers and polypeptide conjugates comprising same |
| 06/14/2001 | WO2001041811A2 Carrier peptide and method for delivery of molecules into cells |
| 06/14/2001 | WO2001041810A2 Nucleic acid delivery system |
| 06/14/2001 | WO2001041809A1 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 06/14/2001 | WO2001041808A1 Medicinal compositions for oral use |
| 06/14/2001 | WO2001041800A2 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 06/14/2001 | WO2001041794A2 Activated amylase |
| 06/14/2001 | WO2001041793A1 A stable aqua formulation of interferon, the preparation method and the uses thereof |
| 06/14/2001 | WO2001041785A2 Enzyme treatment for infection |
| 06/14/2001 | WO2001041776A2 Use of honey in medical dressings |
| 06/14/2001 | WO2001041765A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041758A2 Valnemulin formulation |
| 06/14/2001 | WO2001041757A1 Cyclodextrin-containing pharmaceutical composition |
| 06/14/2001 | WO2001041753A2 Therapeutic compositions and methods for treating periodontitis with antiinflamatory compounds |
| 06/14/2001 | WO2001041744A1 Chronotherapeutic diltiazem formulations and the administration thereof |
| 06/14/2001 | WO2001041737A2 Solid oral dosage form |
| 06/14/2001 | WO2001041736A2 Microchip devices for delivery of molecules and methods of fabrication thereof |
| 06/14/2001 | WO2001041735A2 Thermosensitive biodegradable hydrogels based on low molecular weight pluronics |
| 06/14/2001 | WO2001041734A2 Stable galenic preparations comprising a benzimidazol and method for the production thereof |
| 06/14/2001 | WO2001041733A2 Compressed tablet composition comprising a nsaid |
| 06/14/2001 | WO2001041702A2 Zinc thiosalicylate, dermatological compositions containing same, in particular in the form of a self-adhesive device and method for preparing same |
| 06/14/2001 | WO2001041573A1 Therapeutic antimicrobial compositions |
| 06/14/2001 | WO2001041567A1 Deep penetrating antimicrobial compositions |
| 06/14/2001 | WO2001041550A2 Topical anesthetic formulation |
| 06/14/2001 | WO2001028552A3 Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts |
| 06/14/2001 | WO2001019354A3 Composition for ivf |
| 06/14/2001 | WO2001008632A3 Colloidal composition for esthetic correction |
| 06/14/2001 | WO2000078358A3 Hyaluronic acid microspheres for sustained gene transfer |
| 06/14/2001 | WO1998033528A9 Induction of b cell tolerance |
| 06/14/2001 | US20010003754 Stable liquid mineral ascorbate compositions and methods of manufacture and use |
| 06/14/2001 | US20010003753 Methods for treatment of inflammatory diseases |
| 06/14/2001 | US20010003742 Antilipemic formulation |
| 06/14/2001 | US20010003739 Systemic administration of a therapeutic preparation |
| 06/14/2001 | US20010003619 Comprising an effective proportion of highly crosslinked starch particles with limited swelling, enclosed in a matrix of pregelatinised starch |
| 06/14/2001 | US20010003590 Process for manufacturing tablets for the sustained release of active principle(s) |
| 06/14/2001 | US20010003589 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoxylated saturated hydroxy-fatty acid |
| 06/14/2001 | US20010003580 Dissolving a lipid blend in a nonaqueous solvent and adding it to water or an aqueous solution of brine and/or glycerin and/or solvent; uniform particle size; ultrasound contrast agents |
| 06/14/2001 | CA2394928A1 Amphiphilic polymers and polypeptide conjugates comprising same |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2393737A1 Compositions containing itraconazole with improved bioavailability and narrow intra- and inter-individual variation of its absorption |